期刊文献+

终末期肝病模型评分联合D-二聚体判断食管胃静脉曲张破裂出血患者预后的研究 被引量:4

原文传递
导出
摘要 传统的Child-Turcotte-Pugh(CTP)肝功能分级在临床应用已有数十年历史,但因其采用的大部分指标受主观影响大且较笼统而受到质疑。近年来终末期肝病模型(MELD)对肝硬化失代偿期尤其是终末期肝病病情评估越来越受到重视。
出处 《中华消化内镜杂志》 北大核心 2011年第6期335-337,共3页 Chinese Journal of Digestive Endoscopy
  • 引文网络
  • 相关文献

参考文献11

二级参考文献14

  • 1[3]Villeneuve JP,Wight T,Rakela J,et al.Lamivudine for decompensated cirrhosis resulting form chronic hepatitis B[J].Hepatology,2000,31:207~310.
  • 2[4]Tsang SW,Chan HL,Leung NW,et al.Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection[J].Aliment Pharmacol Ther,2001,15(11):1737~1744.
  • 3[5]Lee WC,Wu MJ,Cheng CH,et al.Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients[J].Am J Kidney Dis,2001,38(5):1074~1081.
  • 4慢性肝病临床并发症[M].现代诊治概念,2001.25.
  • 5Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease [J], Hepatology, 2001, 33: 464-470.
  • 6Kamath PS, Wiesner RH, Malinchoc M, et al. A Model to predict survival in patients with eng-stage liver disease [ J ]. Hepatology, 2001,33:464 -470.
  • 7Wiesner RH, MCDiarmid SV, Kamath PS, et al. MELD and PELD application of surviual models to liver allocation [ J ]. Liver Transpl, 2001,7 : 567 - 580.
  • 8Robert A, Chazouilleres O. Prothrombin time in liver failure : time, ratio, activity percentage, or interntional normalized ratio [ J ]. Hepatology, 1996,24 : 1392 - 1394.
  • 9Kamath P S, Wiesner R H, Malinchoc M, et al. A model to predict survival in patients with end stage liver disease [J]. Hepatology, 2001,33(2 ) :464-470.
  • 10New MELD Liver Transplant Criteria Have Decreased Waiting List Death Rate [J]. Arch Surg, 2007,142( 11 ) : 1079-1085.

共引文献88

同被引文献27

  • 1彭梅,李凤华,夏建国,李继强,李红丽,王晓燕.彩色多普勒超声预测肝硬化食管静脉曲张破裂出血[J].世界华人消化杂志,2004,12(8):1894-1896. 被引量:19
  • 2宋花玲,贺佳,虞慧婷,李玲.应用ROC曲线下面积对两相关诊断试验进行评价和比较[J].第二军医大学学报,2006,27(5):562-563. 被引量:73
  • 3Garcia-Tsao G, Sanyal A J, Grace ND, et al; Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis [ J ]. Am J Gastroenterol, 2007, 102 ( 9 ) : 2086-2102.
  • 4Fong TV, Hung FC, Chiu KW, et al. Model for end-stage liver disease (MELD) score for predicting late esophageal varices rebleeding in cirrhotic patients [ J ]. Hepatogastroenterology,2008, 55 (84) : 1055-1058.
  • 5Wiesner R, Edwards E, Freeman R, et al ; United Network for Organ Sharing Liver Disease Severity Score. Model for end-stage liver disease (MELD) and allocation of donor livers[J]. Gastroenterology, 2003, 124 (1) : 91-96.
  • 6Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease[ J]. Hepatology, 2001, 33 (2): 464-470.
  • 7Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death [J]. Hepatology, 2004, 40 (4) : 802-810.
  • 8Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list[J]. N Engl J Med, 2008, 359 (10) : 1018-1026.
  • 9Siringo S, Bolondi L, Gaiani S, et al. Timing of the first variceal hemorrhage in cirrhotic patients: prospective evaluation of Doppler flowmetry, endoscopy and clinical parameters[J]. Heoatoloaw. 1994 20 ( 1 Pt 1 ) : 66-73.
  • 10Borroni G,Maggi A ,Sangiovanni A,et al. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients[J]. Dig Liver Dis, 2000,32(7) :605-610.

二级引证文献24

;
使用帮助 返回顶部